Sign in

CIK 0001984086 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Septerna, Inc.

Sign in to watch
Ticker
SEPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843891440
Phone
650-338-3533
Business address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,210,085
in 3 filings, $4.2M under 10b5-1 plans

Net −$4,210,085. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ezekowitz Alan −$3.9M Director sold 70% of stake
  2. Bhatt Elizabeth −$150K President and COO sold 2% of stake
  3. Long Daniel D. −$126K SVP, Drug Discovery sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −6,939 $46.01 $319K 110,481
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −13,201 $47.01 $621K 97,280
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −22,865 $47.78 $1.1M 74,415
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −31,572 $48.70 $1.5M 42,843
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −4,175 $49.65 $207K 38,668
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −2,013 $50.90 $102K 36,655
2026-11-11 Ezekowitz Alan Director Sale 10b5-1 −1,055 $51.90 $55K 35,600
2026-06-26 Ezekowitz Alan Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2025-06-17 Ezekowitz Alan Director Grant or award · Stock Option (Right to Buy) +16,623 16,623
2025-03-07 Ezekowitz Alan Director Purchase +13,319 $6.93 $92K 117,420
2025-03-06 Ezekowitz Alan Director Purchase +41,355 $6.00 $248K 104,101
2025-03-05 Ezekowitz Alan Director Purchase +37,835 $5.82 $220K 62,746
2025-03-04 Ezekowitz Alan Director Purchase +7,491 $6.35 $48K 24,911

Page 1 of 1 · 13 trades